Skip to main content
. 2021 Mar 10;12:627423. doi: 10.3389/fimmu.2021.627423

Table 3.

B Lymphocytes subsets.

Controls n = 125 GLILD n = 47 uILD n = 26 p value p value p value
Median (IQR) Median (IQR) Median (IQR) (GLILD vs. ctrls) (uILD vs. GLILD) (uILD vs. ctrls)
Lymphocytes % 29.0 (22.3–37.6) 27.8 (21.8–39.4) 29.0 (26.0–35.0) 0.87 0.54 0.93
Lymphocytes count 2.05 (1.4–2.6) 1.54 (0.99–2.57) 1.87 (1.10–2.30) 0.02 0.67 0.44
CD19+ B cells (% of lymphocytes) 7.0 (3.0–12.6) 6.0 (3.0–10.0) 4.0 (2.0–11–0) 0.91 0.17 0.32
Naïve (% of B cells) 72 (56.6–86.0) 81.2 (54.2–88.2) 75.9 (52.0–81.2) 0.48 0.10 0.63
Switched memory (% of B cells) 2.5 (1.0–6.6) 1.3 (0.1–5.0) 3.0 (0.6–5.9) 0.043 0.20 0.71
Marginal zone (% of B cells) 11.1 (2.4–24.6) 3.5 (1.3–11.0) 8.0 (5.0–16.7) 0.043 0.27 0.48
Transitional (% of B cells) 1.0 (0.2–2.5) 0.6 (0.0–4.0) 2.7 (0.6–7.5) 0.94 0.14 0.09
Plasmablasts (% of B cells) 0.1 (0.0–0.8) 0.3 (0.0–1.1) 0.1 (0.0–1.2) 0.11 0.47 0.66
CD21lo (% of B cells) 3.9 (1.9–7.7) 14.2 (10.1–30.0) 6.0 (2.8–29.3) <0.0001 0.24 0.051

B cells sub-populations are identified according to EUROclass study: Naïve IgD+IgM+CD27; Switched memory IgDIgMCD27+; Marginal zone IgD+IgM+CD27+; Transitional CD38++IgMhigh; Activated CD21lowCD38low; Plasmablasts CD38+++IgM(25).